dc.date.accessioned | 2023-03-06T07:31:59Z | |
dc.date.available | 2023-03-06T07:31:59Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Bosn J Basic Med Sci. 2022 Sep 16;22(5):818-825. doi: 10.17305/bjbms.2021.7069. | |
dc.identifier.uri | https://hdl.handle.net/20.500.12619/100107 | |
dc.relation.isversionof | 10.17305/bjbms.2021.7069 | |
dc.relation.isversionof | 10.17305/bjbms.2021.7069 | |
dc.title | First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer | |
dc.relation.journal | Bosn J Basic Med Sci | |
dc.identifier.doi | 10.17305/bjbms.2021.7069 | |
dc.contributor.author | Aktürk Esen S | |
dc.contributor.author | Aktürk Esen S | |
dc.contributor.author | Ergun Y | |
dc.contributor.author | Erol C | |
dc.contributor.author | Arikan R | |
dc.contributor.author | Er MM | |
dc.contributor.author | Atci MM | |
dc.contributor.author | Topçu A |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |